roomChemin de Blandonnet 10 – BIBC III – 8th Floor 1214 Vernier, Switzerland
arrow_backSee all Activities

Ensuring access to the HCV treatment revolution for HCV/HIV co-infected patients in low and middle income countries

IATI Identifier: XM-DAC-30010-utd-msf_hcv
Published in IATI IATI
  • date_range Jan 01, 2015 - Dec 31, 2017
  • autorenew Finalisation (Status)

The 3-year project plans to shape sustainable markets to ensure those living with HIV-HCV in low- and middle-income countries have rapid access to products for HCV, taking advantage of changes to the HCV landscape, including entry of directly-acting antivirals (DAAs) that are administered orally


Participating Organisations

Organisation Name Organisation Type Organisation Role
Medicins sans Frontiers (MSF) International NGO Implementing


Transaction Value Provider Receiver Type Date
3,150,524 USD (Valued at Jul 24, 2018) circle Unitaid circle Medicines sans Frontieres Disbursement date_rangeJul 24, 2018
1,908,819 USD (Valued at Jul 11, 2017) circle Provider N/A circle Receiver N/A Disbursement date_rangeJul 11, 2017
2,005,000 USD (Valued at Jun 25, 2015) circle Provider N/A circle Doctors Without Borders Disbursement date_rangeJun 25, 2015
14,981,330 USD (Valued at Feb 25, 2015) circle Provider N/A circle Doctors Without Borders Commitment date_rangeFeb 25, 2015


access_timeUpdated on Jul 27, 2018 08:07:34
View XML file here